Streetbeat News

Analyst Ratings

JRSH

Jerash Holdings (US) (NASDAQ:JRSH) reported Q1 earnings of $0.04 per share, beating the analyst consensus estimate of $0.02 by 100%. However, this is a 71.43% decrease from the same period last year. The company also reported quarterly sales of $34.74 million, beating the analyst consensus estimate of $31.25 million by 11.15%, a 3.88% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:03 pm

RGA

Citigroup analyst Michael Ward has maintained a 'Buy' rating on Reinsurance Gr (NYSE:RGA) but lowered the price target from $170 to $162.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 12:02 pm

IFF

Analysts have provided various ratings for Intl Flavors & Fragrances (IFF) in the last quarter, with 1 bullish, 5 somewhat bullish, and 4 indifferent. The company has an average 12-month price target of $97.6, representing a 14.39% decrease from the previous average price target of $114.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 12:01 pm

DDOG

In the last quarter, Datadog (NASDAQ:DDOG) has received mostly bullish ratings from analysts. The company has an average 12-month price target of $114.87, which has increased by 13.38% over the past month. In the last 3 months, 15 analysts have offered 12-month price targets for Datadog.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 12:00 pm

IOVA

Iovance Biotherapeutics (NASDAQ:IOVA) has received predominantly bullish ratings from analysts in the last quarter. The average 12-month price target for the company has increased by 49.64% over the past month, currently standing at $27.31.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 12:00 pm

DISH

In the last quarter, DISH Network (NASDAQ:DISH) has received mixed analyst ratings with 1 bullish, 2 indifferent, and 2 somewhat bearish. The company's average 12-month price target is $9.6, representing a 34.92% decrease from the previous average price target of $14.75.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 12:00 pm

RNA

Avidity Biosciences (NASDAQ:RNA) has received positive analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish ratings. The company's average price target has increased by 4.63% from the previous average of $27.00 to $28.25.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 12:00 pm

MARA

In the last quarter, Marathon Digital Holdings (NASDAQ:MARA) received three bullish ratings and one indifferent rating from analysts. The company's average 12-month price target has increased by 125.0% from the previous average of $7.00 to $15.75, with a high of $20.00 and a low of $8.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 12:00 pm

GTLS

Wells Fargo analyst Roger Read has upgraded Chart Industries (NYSE:GTLS) from Equal-Weight to Overweight and raised the price target from $162 to $224.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 11:59 am

MET

Citigroup analyst Michael Ward has maintained a 'Buy' rating on MetLife (NYSE:MET) and raised the price target from $76 to $81.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 11:59 am